191 related articles for article (PubMed ID: 1383338)
21. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life.
Luzuriaga K; Holmes D; Hereema A; Wong J; Panicali DL; Sullivan JL
J Immunol; 1995 Jan; 154(1):433-43. PubMed ID: 7995957
[TBL] [Abstract][Full Text] [Related]
22. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
Evans DT; O'Connor DH; Jing P; Dzuris JL; Sidney J; da Silva J; Allen TM; Horton H; Venham JE; Rudersdorf RA; Vogel T; Pauza CD; Bontrop RE; DeMars R; Sette A; Hughes AL; Watkins DI
Nat Med; 1999 Nov; 5(11):1270-6. PubMed ID: 10545993
[TBL] [Abstract][Full Text] [Related]
23. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
Rivière Y
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
[TBL] [Abstract][Full Text] [Related]
24. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
[TBL] [Abstract][Full Text] [Related]
25. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
28. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
[TBL] [Abstract][Full Text] [Related]
29. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers.
Cheynier R; Langlade-Demoyen P; Marescot MR; Blanche S; Blondin G; Wain-Hobson S; Griscelli C; Vilmer E; Plata F
Eur J Immunol; 1992 Sep; 22(9):2211-7. PubMed ID: 1381309
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.
Jassoy C; Harrer T; Rosenthal T; Navia BA; Worth J; Johnson RP; Walker BD
J Virol; 1993 May; 67(5):2844-52. PubMed ID: 7682629
[TBL] [Abstract][Full Text] [Related]
32. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ
AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
Cao H; Kanki P; Sankalé JL; Dieng-Sarr A; Mazzara GP; Kalams SA; Korber B; Mboup S; Walker BD
J Virol; 1997 Nov; 71(11):8615-23. PubMed ID: 9343219
[TBL] [Abstract][Full Text] [Related]
36. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
Altfeld MA; Trocha A; Eldridge RL; Rosenberg ES; Phillips MN; Addo MM; Sekaly RP; Kalams SA; Burchett SA; McIntosh K; Walker BD; Goulder PJ
J Virol; 2000 Sep; 74(18):8541-9. PubMed ID: 10954555
[TBL] [Abstract][Full Text] [Related]
37. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
Lubaki MN; Egan MA; Siliciano RF; Weinhold KJ; Bollinger RC
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1427-31. PubMed ID: 7888197
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression.
Lubaki NM; Ray SC; Dhruva B; Quinn TC; Siliciano RF; Bollinger RC
J Infect Dis; 1997 Jun; 175(6):1360-7. PubMed ID: 9180175
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection.
Pontesilli O; Klein MR; Kerkhof-Garde SR; Pakker NG; de Wolf F; Schuitemaker H; Miedema F
J Infect Dis; 1998 Oct; 178(4):1008-18. PubMed ID: 9806028
[TBL] [Abstract][Full Text] [Related]
40. CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual.
Curiel TJ; Wong JT; Gorczyca PF; Schooley RT; Walker BD
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):61-8. PubMed ID: 7678973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]